Biotechs always have some news movers regardless of which direction the markets are headed. Here are some of the top movers in biotech today, although we would note that many ... Read Full Story »
Acorda Therapeutics inc. (NASDAQ: ACOR) showed late stage trial results on its drug candidate Fampridine-SR for treating multiple sclerosis. This data showed that Fampridine, which is designed to treat multiple ... Read Full Story »
(ACOR) Acorda COO resigned to pursue other interests.(AMD) Advanced Micro Devices traded up 4% after revenues were ahead of plan on processor sales.(AUY) Yamana Gold makes business combination offer for ... Read Full Story »
ACLI cut to Hold at Deutsche Bank.ACOR raised to Buy at B of A.AGO cut to Underweight at JPMorgan.ANAD started as Buy at Oppenheimer.ANET cut to Neutral at Baird.ATHR started ... Read Full Story »
(AAUK) Anglo American’s CEO will become a non-executive member of the board of directors at BP (BP).(ACAD) Acadia Pharmaceuticals traded up over 10% after Jim Cramer touted the stock as ... Read Full Story »